Table 1.
Pathway | Study system | Angiogenic phenotype | Reference |
---|---|---|---|
Bone morphogenetic protein | Morpholino knockdown in zebrafish | Fewer ventral sprouting events, dorsal and intersegmental vessel malformation, fewer vascular branches | (7) |
PARP-1 | Tie2-Cre in mice | Increased retinal neovascularization, increased endothelial proliferation | (5) |
Sphingosine-1-phosphate | Meox2-Cre in mice | Interrupted endothelial integrity, embryos with extensive hemorrhage | (6) |
Urokinase-type plasminogen activator (uPA) | LRP1 Ab and antagonist-receptor-associated protein (RAP) in PMVECs | Inhibition of uPA-induced vascular permeability | (32) |
VEGF | Antagonist RAP in HUVEC | Inhibition of VEGF-induced endothelial migration, proliferation, and permeability | (33) |